Interaction of lumican with aggrecan in the aging human sclera

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 11, 2004, Pages 3849-3856

  Dunlevy, Jane R ^a   Summers Rada, Jody A ^b  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BETA GALACTOSIDASE; CHONDROITIN ABC LYASE; LUMICAN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHILD; HUMAN; HUMAN TISSUE; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN PROTEIN INTERACTION; SCLERA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGGRECANS; AGING; BLOTTING, WESTERN; CHILD; CHROMATOGRAPHY, AFFINITY; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; GLYCOSYLATION; HUMANS; IMMUNOENZYME TECHNIQUES; KERATAN SULFATE; LECTINS, C-TYPE; MIDDLE AGED; MOLECULAR WEIGHT; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; SCLERA;

EID: 6944237179     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0496     Document Type: Article

References (53)

1. Hassell JR, Blochberger TC, Rada JA, Chakravarti S, Noonan D. Proteoglycan gene families. In: Binar EE, Kleinman HK. Advances in Molecular and Cell Biology: Extracellular Matrix. Vol. 6. Greenwich, CT: JAI Press; 1993:69-113.
2. Rada JA, Achen VR, Peny CA, Fox PW. Proteoglycans in the human sclera: evidence for the presence of aggrecan. Invest Ophthalmol Vis Sci. 1997;38:1740-1751.
3. Rada JA, Achen VR, Penagonda S, Mount BA. Proteoglycan composition in the human sclera during growth and aging. Invest Ophthalmol Vis Sci. 2000;41:1639-1648.
4. Muir H. Proteoglycans as organizers of the intercellular matrix. Seventeenth CIBA Medical Lecture. Biochem Soc Trans 1982;11:613-622.
5. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol. 1998;17:1-19.
6. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol. 1997;32:141-174.
7. Young TL, Guo XD, King RA, Johnson JM, Rada JA. Identification of genes expressed in a human scleral cDNA library. Mol Vis. 2003;9:508-514.
8. Iozzo RV. The biology of the small leucine-rich proteoglycans. J Biol Chem. 1999;274:18843-18846.
9. Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal keratan sulfate proteoglycan (lumican) and decorin core proteins. Exp Eye Res. 1993;56:635-648.
10. Neame PJ, Kay CJ, McQuillan DJ, Beales MP, Hassell JR. Independent modulation of collagen fibrillogenesis by decorin and lumican. Cell Mol Life Sci. 2000;57:859-863.
11. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol. 2000;151:779-788.
12. Chakravarti S, Petroll WM, Hassell JR, et al. Corneal opacity in lumican-null mice: defects in collagen fibril structure and packing in the posterior stroma. Invest Ophthalmol Vis Sci. 2000;41:3365-3373.
13. Austin BA, Coulon C, Liu C-Y, Kao WW-Y, Rada JA. Altered collagen fibril formation in the sclera of lumican-deficient mice. Invest Ophthalmol Vis Sci. 2002;43:1695-1701.
14. Chakravarti S, Paul J, Roberts L, Chervoneva I, Oldberg A, Birk DE. Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest Ophthalmol Vis Sci. 2003;44:2422-2432.
15. Nakazawa K, Newsome DA, Nilsson B, Hascall VC, Hassell JR. Purification of keratan sulfate proteoglycan from monkey cornea. J Biol Chem. 1983;258:6051-6055.
16. Oeben M, Keller R, Stuhlsatz HW, Greiling H. Constant and variable domains of different disaccharide structure in corneal keratan sulphate chains. Biochem J. 1987;248:85-93.
17. Nilsson B, Nakazawa K, Hassell JR, Newsome DA, Hascall VC Structure of oligosaccharides and the linkage region between keratan sulfate and the core protein on proteoglycans from monkey cornea. J Biol Chem. 1983;258:6056-6063.
18. Dunlevy JR, Neame PJ, Vergnes JP, Hassell JR. Identification of the N-linked oligosaccharide sites in chick corneal lumican and keratocan that receive keratan sulfate. J Biol Chem. 1998;273:9615-9621.
19. Funderburgh JL, Funderburgh ML, Mann MM, Conrad GW. Arterial lumican. Properties of a corneal-type keratan sulfate proteoglycan from bovine aorta. J Biol Chem. 1991;266:24773-24777.
20. Melching LI, Roughley PJ. Modulation of keratan sulfate synthesis on lumican by the action of cytokines on human articular chondrocytes. Matrix Biol. 1999;18:381-390.
21. Grover J, Chen XN, Korenberg JR, Roughley PJ. The human lumican gene: organization, chromosomal location, and expression in articular cartilage. J Biol Chem. 1995;270:21942-21949.
22. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
23. Sandy JD, Plaas AHK, Koob TJ. Pathways of aggrecan processing in joint tissues. Acta Orthop Scand. 1995;66:26-32.
24. Sandy JD, Gamett D, Thompson V, Verscharen C. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J. 1998;335:59-66.
25. Gong H, Ye W, Freddo TF, Hernandez MR. Hyaluronic acid in the normal and glaucomatous optic nerve. Exp Eye Res. 1997;64:587-595.
26. Brown CT, Vural M, Johnson M, Trinkaus-Randall V. Age-related changes of scleral hydration and sulfated glycosaminoglycans. Mech Ageing Dev. 1994;77:97-107.
27. Doege KJ, Sasaki M, Kimura T and Yamada Y. Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan human specific repeats, and additional alternatively spliced forms. J Biol Chem. 1991;266:894-902.
28. Morgelin M, Paulsson M, Hardingham TE, Heinegard D, Engel J. Cartilage proteoglycans: assembly with hyaluronate and link protein as studied by electron microscopy. Biochem J. 1988;253:175-185.
29. Paulsson M, Morgelin M, Wiedemann H, et al. Extended and globular protein domains in cartilage proteoglycans. Biochem J. 1987;245:763-772.
30. Wells T, Davidson C, Morgelin M, Bird JL, Bayliss MT, Dudhia J. Age-related changes in the composition, the molecular stoichiometry and the stability of proteoglycan aggregates extracted from human articular cartilage. Biochem J. 2003;370:69-79.
31. Bayliss MT. Proteoglycan structure and metabolism during maturation and ageing of human articular cartilage. Biochem Soc Trans. 1990;18:799-802.
32. Arner EC. Aggrecanase-mediated cartilage degradation. Curr Opin Pharmacol. 2002;2:322-329.
33. Roughley PJ, Barnett J, Zuo F, Mort JS. Variations in aggrecan structure modulate its susceptibility to aggrecanases. Biochem J. 2003;375:183-189.
34. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid: evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest. 1992;89:1512-1516.
35. Little CB, Flannery CR, Hughes CE, et al. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem J. 1999;344:61-68.
36. Flannery CR, Lark MW, Sandy JD. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. J Biol Chem. 1992;267:1008-1014.
37. Fosang AJ, Neame PJ, Last K, Hardingham TE, Murphy G, Hamilton JA. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J Biol Chem. 1992;267:19470-19474.
38. Rabek JP, Boylston WH III, Papaconstantinou J. Carbonylation of ER chaperone proteins in aged mouse liver. Biochem Biophys Res Commun. 2003;305:566-572.
39. Sullivan R. Contributions to senescence: non-enzymatic glycosylation of proteins. Arch Physiol Biochem. 1996;104:797-806.
40. Aronson D. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes. J Hypertens. 2003;21:3-12.
41. Park SC, Yeo EJ, Han JA, et al. Aging process is accompanied by increase of transglutaminase C. J Gerontol A Biol Sci Med Sci. 1999;54:B78-B83.
42. Rosenthal AK, Derfus BA, Henry LA. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum. 1997;40:966-970.
43. Shin DM, Jeon JH, Kim CW, et al. Cell-type specific activation of intracellular transglutaminase 2 by oxidative stress or UV irradiation: implications of transglutaminase 2 in age-related cataractogenesis. J Biol Chem. 2004;279:15032-15039.
44. Kim SY, Jeitner TM, Steinert PM. Transglutaminases in disease. Neurochem Int. 2002;40:85-103.
45. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes-with pleiotropic functions. Nat Rev Mol Cell Biol. 2003;4:140-156.
46. Vertel BM, Ratcliffe A. Aggrecan. In: Iozza RV, ed. Proteoglycans: Structure, Biology and Molecular Interactions. New York, NY: Marcel Dekker, Inc. 2000;343-377.
47. Spector A, Freund T, Li LK, Augusteyn RC. Age-dependent changes in the structure of alpha crystallin. Invest Ophthalmol. 1971;10:677-686.
48. Jedziniak JA, Kinoshita JH, Yates EM, Hocker LO, Benedek GB. On the presence and mechanism of formation of heavy molecular weight aggregates in human normal and cataractous lenses. Exp Eye Res. 1973;15:185-192.
49. Takemoto L. Increase in the intramolecular disulfide bonding of alpha-A crystalline during aging of the human lens. Exp Eye Res. 1996;63:585-590.
50. Friedman E, Ivry M, Ebert E, Glynn R, Gragoudas E, Seddon J. Increased scleral rigidity and age-related macular degeneration. Ophthalmology. 1989;96:104-108.
51. Toris CB, Yablonski ME, Wang YL, Camras CB. Aqueous humor dynamics in the aging human eye. Am J Ophthalmol. 1999;127:407-412.
52. Friberg TR, Lace JW. A comparison of the elastic properties of human choroid and sclera. Exp Eye Res. 1988;47:429-436.
53. Lam AK, Chan ST, Chan H, Chan B. The effect of age on ocular blood supply determined by pulsatile ocular blood flow and color Doppler ultrasonography. Optom Vis Sci. 2003;80:305-311.